Lv0
0 积分 2025-11-25 加入
Case 28-2024: A 75-Year-Old Woman with Edema, Arthritis, and Proteinuria
2个月前
已完结
Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in patient‐reported symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trials
2个月前
已完结
Consensus on the whole-process management of atopic dermatitis
2个月前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
4个月前
已完结
Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial
5个月前
已完结
Fast, Present and Future of the Concept of Spondyloarthritis
6个月前
已完结
POS0262 IVARMACITINIB IMPROVES DIFFERENT DIMENSIONS OF PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: A POST-HOC ANALYSIS OF A PHASE II/III TRIAL
6个月前
已关闭
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
6个月前
已完结
POS0803 VUNAKIZUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLIND, ADAPTIVE, SEAMLESS, PHASE 2/3 STUDY
6个月前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
6个月前
已完结
皖公网安备34019202002308
